Bushido Capital US Equity (SMRI) ETF Holdings & Analysis
ETFOther
Track SMRI in your portfolio for free · Portfolio tracker
What SMRI does
Operating as an actively managed exchange-traded fund (ETF), this fund endeavors to achieve its financial objectives primarily through investing in U.S.-listed common equities. Customarily, at least 80% of its combined assets—comprising both net assets and any borrowed funds used for investment—are allocated to these securities.
Fund profile
Top holdings
| Holding | Weight | |
|---|---|---|
| Accenture PLC | 2.54% | |
| United Therapeutics Corp | 2.37% | |
| ConocoPhillips | 2.27% | |
| Intuit Inc | 2.25% | |
| Cognizant Technology Solutions Corp | 2.24% | |
| EOG Resources Inc | 2.24% | |
| Autodesk Inc | 2.22% | |
| Leidos Holdings Inc | 2.20% | |
| ExxonMobil Holdings Corp | 2.19% | |
| Royalty Pharma PLC | 2.18% |
Geographic allocation
| United States | 95.57% |
| Ireland | 4.44% |
PortView Portfolio Insights
PortView analyzes how SMRI fits your actual portfolio — position weight, ETF overlap with your other funds, sector and geographic exposure, concentration, and how this fund contributes to your portfolio risk and return. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze SMRI in PortView →Related securities
Related stocks
Frequently asked questions
- What does SMRI track?
- SMRI is the Bushido Capital US Equity ETF, a Other ETF.
- What is the expense ratio of SMRI?
- Expense ratio data for SMRI is shown on the page when available from our data provider.
- What are the largest holdings in SMRI?
- Top holdings include ACN, UTHR, COP, INTU, CTSH.
- How can PortView analyze SMRI overlap with other ETFs?
- PortView computes the holdings overlap between SMRI and the other ETFs and stocks you own, plus your combined sector and geographic exposure, so you can see true diversification.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.